Endogenous proteolytic activity in a rat model of spontaneous cerebral stroke

Brain Res. 2003 Jun 6;974(1-2):184-92. doi: 10.1016/s0006-8993(03)02578-2.

Abstract

We evaluated the expression of two extra-cellular protease systems in a model of spontaneous cerebrovascular pathology: spontaneously hypertensive stroke-prone rats (SHRSP). The appearance of brain damage in individual animals was imaged and followed by means of magnetic resonance imaging (MRI). In situ zymography of brain slices obtained 3 days after the appearance of brain damage showed an increase in plasminogen activator (PA)/plasmin activity that co-localised with the cerebral damage detected by MRI; there was also concomitant accumulation/activation of inflammatory cells in the damaged area. Proteolytic activity was inhibited by the urokinase-specific inhibitor amiloride but not by an antibody against tissue-type plasminogen activator (t-PA). SDS-PAGE zymography of brain extracts revealed the presence of 58 kDa plasminogen-dependent lysis areas in the ischemic and non-ischemic tissues, and a 33 kDa lysis area in ischemic tissue only. An antibody against t-PA inhibited the former, whereas the latter was inhibited by amiloride. The specific induction of urokinase-type plasminogen activator (u-PA) in the damaged tissue was further confirmed by the fact that both u-PA protein mass and mRNA were markedly increased in the damaged cerebral areas. Concomitant metalloproteinase-2 (MMP-2) activation was only observed in the damaged area. These data suggest that u-PA is expressed and selectively catalyses proteolysis in the injured area of spontaneous brain damage in SHRSP.

MeSH terms

  • Animals
  • Blotting, Western
  • Electrophoresis, Polyacrylamide Gel
  • Endopeptidases / analysis
  • Endopeptidases / metabolism*
  • Magnetic Resonance Imaging
  • Matrix Metalloproteinase 2 / biosynthesis
  • Matrix Metalloproteinase 2 / genetics
  • Rats
  • Rats, Inbred SHR
  • Reverse Transcriptase Polymerase Chain Reaction
  • Stroke / enzymology*
  • Stroke / genetics
  • Stroke / pathology
  • Tissue Plasminogen Activator / metabolism
  • Urokinase-Type Plasminogen Activator / metabolism

Substances

  • Endopeptidases
  • Tissue Plasminogen Activator
  • Urokinase-Type Plasminogen Activator
  • Matrix Metalloproteinase 2